Ero Copper Reports Record 2025 Financials, Strong Production Growth, and Reaffirms Positive 2026 Guidance
Summary
Ero Copper reported record Q4 and full-year 2025 operating and financial results, including record copper production, significantly improved cash flow and EBITDA, and a strengthened balance sheet, while reaffirming strong 2026 production and cost guidance.
Key Events
-
Record 2025 Financial Performance
Reported record full-year 2025 cash flow from operations of $395.1 million, a 171.7% increase year-on-year, and adjusted EBITDA of $409.7 million, up nearly 90% from 2024.
-
Record Copper Production
Achieved record consolidated copper production of 64,307 tonnes in concentrate for full-year 2025, with Q4 2025 also marking a record at 19,706 tonnes.
-
Strengthened Balance Sheet
Net debt leverage ratio improved significantly to 1.2x at year-end 2025, down from 2.6x at year-end 2024, reflecting a $50.1 million decrease in net debt.
-
Positive 2026 Guidance Reaffirmed
Reaffirmed 2026 guidance, projecting consolidated copper production of 67,500 to 77,500 tonnes (up to 20% increase) and gold production of 40,000 to 50,000 ounces.
Analysis
Ero Copper Corp. delivered exceptional financial and operational results for Q4 and full-year 2025, marked by record copper production and substantial increases in cash flow from operations and adjusted EBITDA. The company significantly strengthened its balance sheet, nearly halving its net debt leverage ratio. Reaffirming its 2026 guidance, which projects up to a 20% increase in consolidated copper production, signals continued growth and operational confidence. The successful gold concentrate program at Xavantina further diversified revenue streams. While the Furnas Copper-Gold Project PEA was previously announced, its reiteration underscores a robust long-term growth strategy, positioning the company favorably for future development.
At the time of this filing, ERO was trading at $29.35 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $3B. The 52-week trading range was $9.30 to $39.80. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.